As of 2026-04-02, 扬子江药业's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 2.86%, below the industry average by 0.1 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Positive mention rate (1.43%) is slightly higher than negative (0.00%), continue monitoring public sentiment. Among 6 competitors in the same category, 扬子江药业's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
扬子江药业's Mention Rate is 2.86%, lower than 0.6% of competitors
扬子江药业's First Mention is 0.00%, lower than 0.9% of competitors
扬子江药业's Preferred Rate is 0.00%, lower than 100.0% of competitors
扬子江药业's Positive Rate is 1.43%, lower than 8.9% of competitors
扬子江药业's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 恒恒瑞医药 | 71.43% | 20% | 38.1% | 65.71% | 5.71% | View Details |
| 百百济神州 | 67.14% | 11.43% | 0% | 58.57% | 1.43% | View Details |
| 礼礼来 | 55.71% | 41.43% | 42.86% | 51.43% | 0% | View Details |
| 中中国生物制药 | 42.86% | 0% | 0% | 34.29% | 0% | View Details |
| 罗罗氏 | 40% | 1.43% | 4.76% | 34.29% | 0% | View Details |
| 荣荣昌生物 | 40% | 0% | 0% | 35.71% | 0% | View Details |
| 扬扬子江药业 (Current Brand) | 2.86% | 0% | 0% | 1.43% | 0% | View Details |
